Mewhort HE, Lipon BD, Svystonyuk DA, Teng G, Guzzardi DG, Silva C, Yong VW, Fedak PW. Monocytes increase human cardiac myofibroblast-mediated extracellular matrix remodeling through TGF-␤ 1. Am J Physiol Heart Circ Physiol 310: H716 -H724, 2016. First published January 22, 2016; doi:10.1152/ajpheart.00309.2015.-Following myocardial infarction (MI), cardiac myofibroblasts remodel the extracellular matrix (ECM), preventing mechanical complications. However, prolonged myofibroblast activity leads to dysregulation of the ECM, maladaptive remodeling, fibrosis, and heart failure (HF). Chronic inflammation is believed to drive persistent myofibroblast activity; however, the mechanisms are unclear. We assessed the influence of peripheral blood monocytes on human cardiac myofibroblast activity in a three-dimensional (3D) ECM microenvironment. Human cardiac myofibroblasts isolated from surgical biopsies of the right atrium and left ventricle were seeded into 3D collagen matrices. Peripheral blood monocytes were isolated from healthy human donors and cocultured with myofibroblasts. Monocytes increased myofibroblast activity measured by collagen gel contraction (baseline: 57.6 Ϯ 5.9% vs. coculture: 65.2 Ϯ 7.1% contraction; P Ͻ 0.01) and increased local ECM remodeling quantified by confocal microscopy. Under coculture conditions that allow indirect cellular interaction via paracrine factors but prevent direct cell-cell contact, monocytes had minimal effects on myofibroblast activity (17.9 Ϯ 11.1% vs. 6.4 Ϯ 7.0% increase, respectively; P Ͻ 0.01). When cells were cultured under direct contact conditions, multiplex analysis of the coculture media revealed an increase in the paracrine factors TGF-␤ 1 and matrix metalloproteinase 9 compared with baseline (122.9 Ϯ 10.1 pg/ml and 3,496.0 Ϯ 190.4 pg/ml, respectively, vs. 21.5 Ϯ 16.3 pg/ml and 183.3 Ϯ 43.9 pg/ml; P Ͻ 0.001). TGF-␤ blockade abolished the monocyte-induced increase in cardiac myofibroblast activity. These data suggest that direct cell-cell interaction between monocytes and cardiac myofibroblasts stimulates TGF-␤-mediated myofibroblast activity and increases remodeling of local matrix. Peripheral blood monocyte interaction with human cardiac myofibroblasts stimulates myofibroblast activity through release of TGF-␤ 1. These data implicate inflammation as a potential driver of cardiac fibrosis. inflammation; cardiac fibrosis; extracellular matrix; cardiac myofibroblasts; remodeling
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NEW & NOTEWORTHY

Peripheral blood monocytes increase cardiac myofibroblast activity through a direct cell-cell mechanism involving the release of TGF-␤ 1 and MMP-9. These data illustrate a mechanism by which inflammation may drive cardiac fibrotic pathologies highlighting potential therapeutic targets.
IMPROVEMENTS IN THE MANAGEMENT of acute coronary syndromes have decreased mortality following acute myocardial infarction (MI) (1, 39) . As a consequence, the incidence, prevalence, and morbidity of post-MI heart failure is on the rise (10, 39) . As of 2013, the prevalence of ischemic heart failure (HF) was 5.1 million Americans (10); a diagnosis that carries a 50% 5-year mortality rate (1) and costs over $32 billion per year (10) . It has been proposed that inflammation following myocardial injury plays a significant role in ongoing myocardial damage, remodeling, fibrosis, and HF (6, 8, 22) . However, the mechanisms by which inflammation affects myocardial remodeling and progressive fibrosis remains elusive.
Ischemic injury of the heart triggers extracellular matrix (ECM) dysregulation leading to interstitial fibrosis and left ventricular dilation, two hallmarks of ischemic HF. The ECM consists of a dynamic network of structural fibers and cellsignaling factors, creating a critical microenvironment that not only provides structural support to tissues, but also regulates cell morphology, differentiation, migration, and proliferation (2, 26) . Resident cardiac fibroblasts, one of the most abundant cell types comprising cardiac tissue, are responsible for the maintenance of ECM homeostasis in the steady state (2, 11, 30) . Following ischemic injury, these quiescent cells undergo phenotypic transdifferentiation to their active myofibroblast form (19, 32) . In their active state, myofibroblasts increase ECM turnover by altering the balance between collagen degradation, by matrix metalloproteases (MMPs), and collagen synthesis favoring an increase in collagen deposition, resulting in scar formation (2) . During the early stages of tissue healing following MI, this process is adaptive, providing structural integrity to necrotic tissues to prevent mechanical complications of MI, such as rupture of the ventricular free wall, papillary muscles, or the interventricular septum. However, chronic and sustained activation of cardiac myofibroblasts may result in dysregulation of ECM homeostasis and cardiac remodeling, chamber dilation, and HF (11, 30) .
Monocytes are key inflammatory mediators of both tissue healing and fibrosis in several pathological processes (19) . Studies in noncardiac tissue systems indicate that monocytes can regulate myofibroblast function and extracellular matrix (ECM) homeostasis, two key contributors to the development and progression of fibrosis (33, 36, 42) . Monocytes are present during both the inflammatory and fibrotic stages of tissue healing after MI and have been implicated as the primary immune cell type involved in the inflammatory response to ischemic injury (18, 28) . Clinical studies have implicated monocytes in the progression to ischemic HF. Patients with monocytosis (the CD14 hi CD16 Ϫ monocyte, in particular) are at increased risk of developing ischemic HF and possess a poorer prognosis (4, 12, 23, 37) . A better understanding of the interactions between monocytes, cardiac myofibroblasts, and the ECM, and how cardiac remodeling is altered by these cellular and molecular mechanisms may be relevant to the development of new therapeutic strategies for the treatment of ischemic heart failure.
MATERIALS AND METHODS
Human cardiac myofibroblast isolation. Cardiac myofibroblasts were isolated from human heart tissue biopsies obtained from consenting patients undergoing cardiac surgery at the Foothills Medical Center (Calgary, AB, Canada) (29) . Atrial cardiac fibroblasts were isolated from transmural biopsies of the right atrial appendage (n ϭ 13). Ventricular cardiac fibroblasts were isolated from transmural biopsies of the left ventricular apex taken at the time of left ventricular assist device insertion (n ϭ 4). All human tissue protocols were approved by the Conjoint Health Research Ethics Board at the University of Calgary and conform to the Declaration of Helsinki. Biopsies were placed in cold Iscove's modified Dulbecco's medium (IMDM; Lonza, Walkersville, MD) and kept on ice until processing. Gross connective and adipose tissues were removed. Tissue was washed twice with PBS (Lonza), minced into 0.5-1-mm fragments, and then plated onto collagen-coated (Sigma-Aldrich, St. Louis, MO) 100-mm Petri dishes (Falcon, Corning, NY), with IMDM supplemented with 10% FBS (Gibco by Life Technologies, Burlington, ON, Canada) plus 50,000 units of penicillin-streptomycin (Life Technologies). Explant tissue was cultured at 37°C in 5% CO 2, and culture medium was replaced every 3 days. A layer of cardiac myofibroblasts spontaneously emerged from edges of adherent explants. Once confluent, cardiac myofibroblasts were harvested by washing explants with PBS, then treating them enzymatically with 3 ml trypsin for 3-5 min at 37°C. Harvested cells were maintained at 37°C within a 5% CO 2 atmosphere, and passages 1-4 were used for experiments.
Human monocyte isolation. Peripheral blood mononuclear cells (PBMCs) were isolated from the peripheral blood of healthy volunteers (n ϭ 4) by centrifugation over a Ficoll-Paque Plus (GE Healthcare, Baie-d'Urfé, QC, Canada) gradient at 1,800 rpm for 30 min. Monocytes were isolated from PBMCs using the EasySep Human CD14-positive selection kit (STEMCELL Technologies, Vancouver, BC, Canada), in accordance with the manufacturer's specifications. Monocytes were suspended in IMDM supplemented with 1% antibiotics (serum-free media, SFM) and freshly applied to coculture experiments.
Cell characterization. Cardiac myofibroblasts have been previously characterized, demonstrating greater than 95% purity of myofibroblasts isolated by the method employed (35) . Monocyte subsets were characterized by flow cytometry. Isolated cells were costained with FITC-conjugated CD14 (MEM-15) antibody (Thermo Scientific, Rockford, IL) for 30 min at 4°C followed by PE-conjugated CD16 (MEM-154) antibody (Thermo Scientific) for 30 min at 4°C. Stained cells were resuspended in FACS buffer, and CD14-and CD16-positive cells were quantified using a flow cytometer. Unstained and conjugated isotype controls were performed for all experiments.
To ensure coculture conditions did not result in cell death, cell viability was assessed in the 3D collagen gel contraction model at 72 h using an annexin-V propidium iodide binding assay, as previously described (35) . In brief, cells were stained with annexin-V and propidium iodide (BD Pharmingen, Becton Dickinson, San Jose, CA), in accordance with the manufacturer's specifications, and annexin-V and propidium iodide-positive cells were quantified by flow cytometry. Unstained and conjugated isotype controls were performed for all experiments.
3D collagen gel contraction model. The 3D collagen gel contraction model has been previously validated as a functional measure of myofibroblast activity, in which percent gel contraction positively correlates to myofibroblasts activity levels (20) . A collagen gel solution was prepared by combining on ice: 10% 10ϫ minimal essential medium (Gibco); rat tail type I collagen (BD Biosciences) to a final concentration of 1.8 mg/ml; 1 N NaOH to a pH of 7-8; and PBS. Human cardiac myofibroblasts, serum-starved for 24 h, were incorporated to achieve a concentration of 2.0 ϫ 10 5 cells per well, and the solution was aliquoted into a 24-well plate. The collagen gel was polymerized at 37°C for 1 h. Once polymerized, a treatment solution of 500 l of SFM alone (representing baseline myofibroblast activity) or in combination with recombinant human-transforming growth factor ␤ 1 (TGF-␤; Gibco, Gaithersburg, MD; 10 ng/ml; positive control known to increase myofibroblast activity) was added to each of the collagen gel-containing wells. Collagen gels were released from the 24-well plate after 24 h and imaged an additional 24 h after release. Images were analyzed using ImageJ (version 1.44g, NIH, Bethesda, MD). Collagen remodeling was indicated by percent contraction, calculated according to the following: %Contraction ϭ [(surface area of the well Ϫ surface area of the collagen gel)/surface area of the well] ϫ 100. Direct cell-cell interaction coculture. Direct cell-cell coculture conditions were achieved by adding freshly isolated human peripheral blood monocytes along with cardiac myofibroblasts to the collagen matrix at a concentration of 4.0 ϫ 10 5 cells per well prior to polymerization. Direct cell-cell interaction between monocytes and cardiac myofibroblasts was confirmed by fluorescence immunocytochemistry. Monocytes were stained with di-8-ANEPPS (1,000:1; Thermo Fischer Scientific, Waltham, MA) for 30 min at 37°C within a 5% CO 2 atmosphere prior to introduction into the collagen gel contraction assay. Following completion of the functional assay, collagen matrices were fixed in 4% paraformaldehyde for 30 min. Collagen matrices were stained with anti-␣-smooth muscle actin (␣-SMA; 1A4) antibody (Sigma-Aldrich) for 1 h at room temperature followed by incubation with diamidinophenylindole (DAPI) for 30 min for nuclear visualization. Cells within the collagen matrices were visualized using a confocal laser microscope (LSM 5; Carl Zeiss, Toronto, ON, Canada).
Indirect coculture. To permit cell-cell communication through paracrine factors without allowing direct cell-cell contact, indirect coculture was achieved by plating freshly harvested peripheral blood monocytes at a concentration of 4.0 ϫ 10 5 cells per well into a 0.4-m pore high-density polyethylene terephthalate cell culture insert (Corning, Corning, NY) seated above the myofibroblast-containing collagen gel within each well. The pore size of the inserts chosen permits diffusion of paracrine factors between the upper and lower chambers within each well, but neither cell type.
ELISA. ELISA were performed by Eve Technologies (Calgary, AB, Canada) on conditioned-media samples (n ϭ 4 per treatment group) from each of the 3D collagen gel experiments to determine the concentration of TGF-␤ and MMP-9 within the conditioned media in response to coculture conditions.
Reagents. TGF-␤ (MAB1835; R&D Systems, Minneapolis, MN) and MMP-9 inhibitors (Calbiochem, Etobicoke, ON, Canada) were added to the SFM treatment solution of 3D collagen gel contraction experiments at a concentration of 0.5 g/ml (3) and 0.1 nM (21), respectively, to determine whether TGF-␤1 and MMP-9 affected monocyte-mediated cardiac myofibroblast activity. Assessment of ECM remodeling. To assess the interaction between monocytes, cardiac myofibroblasts, and the ECM, we employed a 3D collagen matrix cell culture platform, as previously described (35) . In brief, collagen micromatrices were created using type I bovine dermal collagen (5.9 mg/ml; Advanced Biomatrix, San Diego, CA) diluted to 1.0 mg/ml, neutralized to a pH ϭ ϳ7.4 using 0.1 N NaOH, and polymerized onto a nylon grid. Three-dimensional collagen micromatrices were seeded with 1 ϫ 10 4 human cardiac myofibroblasts alone and in combination with 2 ϫ 10 4 freshly isolated human peripheral blood monocytes in SFM.
After 24 h, local ECM remodeling was quantified by measuring collagen fiber alignment (35) visualized by confocal reflectance microscopy, as we have previously described (29, 24, 25, 31) . In brief, a fast Fourier transform was employed to quantify the distribution of collagen fiber angles referenced to the frame of the acquired image measured as pixel intensity at any given angle. An intensity curve is generated to display the pixel intensities across all 180°. Random fiber distribution results in a uniform pixel intensity across all angles, while fiber alignment results in an increase in pixel intensity at a particular angle. The degree of ECM remodeling is then quantified by calculating the collagen fiber alignment index; the area under the curve bound by the peak intensity value Ϯ 10°. Larger index values indicate greater ECM remodeling.
Statistical analysis. When only two groups were compared, a two-tailed Student's t-test or paired t-test was performed where appropriate. For comparison of more than two groups, one-way ANOVA was used followed by a post hoc Tukey's test. Significance was determined by a P value Ͻ 0.05. Results are given as means Ϯ SD.
RESULTS
Cell characterization. Patient characteristics from which atrial and ventricular cardiac myofibroblasts were isolated are described in Tables 1 and 2 , respectively. We have previously characterized isolated myofibroblasts demonstrating greater than 95% purity, with positive staining for markers of myofibroblast phenotype, including ␣-SMA, fibronectin, vimentin, discoidin domain receptor-2, and negative staining for markers of other cardiac cell phenotypes, including troponin-I, desmin, and von Willebrand factor (35, 29) .
The subset composition of isolated monocytes used in all experiments was characterized by flow cytometry. Isolated monocytes from healthy donors (n ϭ 3) comprised 95. hi monocytes (Fig. 1, A and B) . Cell viability was also characterized following collagen gel contraction experiments to determine the effects of coculture conditions on cell viability. Cardiac myofibroblast cell viability was greater than 97% irrespective of whether myofibroblasts Fig. 2 . A: representative results from a threedimensional collagen gel contraction experiment depicting collagen gel contraction, indicative of myofibroblast activity at baseline (myofibroblasts alone in the gel), in response to TGF-␤ (myofibroblasts ϩ TGF-␤), in response to direct coculture with monocytes (myofibroblasts ϩ monocytes) and monocytes alone. B: percent collagen gel contraction demonstrating monocytes increase atrial myofibroblast activity compared with myofibroblasts cultured alone, similar to the TGF-␤-positive control (myofibroblasts alone: 57.6 Ϯ 5.9% vs. myofibroblasts ϩ TGF-␤: 73.4 Ϯ 0.8% vs. myofibroblasts ϩ monocytes: 65.2 Ϯ 7.1%; **P Ͻ 0.01; n ϭ 6). C: Western blot data demonstrating a similar increase in ␣-SMA levels in cardiac myofibroblasts directly cocultured with monocytes compared with cardiac myofibroblasts cultured in isolation (0.99 vs. 0.35-fold relative to GAPDH, respectively; n ϭ 1). D: percent Percent collagen gel contraction demonstrating monocytes increase ventricular myofibroblast activity compared with myofibroblasts cultured alone, similar to the TGF-␤-positive control (myofibroblasts alone: 53.4 Ϯ 10.0% vs. myofibroblasts ϩ TGF-␤: 67.8 Ϯ 8.6% vs. myofibroblasts ϩ monocytes: 64.7 Ϯ 6.7%; *P Ͻ 0.05; n ϭ 4). TGF-␤, transforming growth factor beta; ␣-SMA, alpha-smooth muscle actin.
were cultured alone or cocultured with monocytes (Fig. 1, C  and D) .
Monocytes increase cardiac myofibroblast activity. The effect of monocyte and atrial cardiac myofibroblast interactions on functional cardiac myofibroblast activity was determined using the 3D collagen gel model. Cardiac myofibroblasts within the collagen matrix produced a baseline level of collagen gel remodeling (57.6 Ϯ 5.9% contraction). The addition of TGF-␤ 1 , an established potent activator of myofibroblast activity, was used as a positive control to confirm the capacity for increased cardiac myofibroblast activity above baseline in all experiments (Fig. 2, A and B) . Direct coculture of monocytes and cardiac myofibroblasts resulted in an increase in collagen matrix remodeling, similar to that observed with the addition of exogenous TGF-␤ 1 (65.2 Ϯ 7.1% vs. 73.4 Ϯ 0.8% contraction, respectively; P Ͻ 0.01). Monocytes cultured alone in the 3D collagen gel contraction assay did not result in collagen gel remodeling (0.8 Ϯ 2.0% contraction; Fig. 2, A and B) . The increase in functional activation of atrial cardiac myofibroblasts was confirmed by Western blot for ␣-SMA, demonstrating an increase in ␣-SMA protein relative to GAPDH in cardiac myofibroblasts after 72 h in the collagen gel contraction assay (Fig. 2C) . Monocytes also increased ventricular cardiac myofibroblast activity demonstrated by an increase in collagen gel remodeling compared with baseline (64.7 Ϯ 6.7% vs. 53.4 Ϯ 9.9% contraction, respectively; P Ͻ 0.05; Fig. 2D ).
Monocyte-mediated increase in cardiac myofibroblast activity occurs through a direct cell-cell mechanism.
To determine whether the monocyte-mediated increase in cardiac myofibroblast activity is dependent on direct cell-cell interaction, 3D collagen gel contraction performed under indirect co-culture conditions (where monocytes and cardiac myofibroblasts were separated by a membrane permeable only to paracrine factors) and direct coculture conditions (where monocytes and cardiac myofibroblasts were cultured in direct proximity within the collagen gel) were compared (Fig. 3A) . While direct coculture conditions resulted in increased cardiac myofibroblast activity as measured by increased collagen gel remodeling above baseline, indirect coculture conditions produced only a trend toward a modest increase in cardiac myofibroblast activity (17.9 Ϯ 11.1% vs. 6.4 Ϯ 7.0%, respectively; P Ͻ 0.01; Fig.  3B ), indicating that the monocyte-mediated increase in cardiac myofibroblast activity requires direct cell-cell interaction. This direct cell-cell interaction between monocytes and cardiac myofibroblasts was visualized by fluorescence immunocytochemistry (Fig. 3C) .
TGF-␤ 1 release and monocyte-mediated increase in cardiac myofibroblast activity. To determine whether the monocytemediated increase in cardiac myofibroblast activity involves a paracrine mechanism, cytokine profiles of conditioned media from baseline, indirect and direct coculture 3D collagen gel contraction experiments were compared by high-throughput ELISA. Under baseline and indirect coculture conditions, a modest production of TGF-␤ 1 was observed (21.5 Ϯ 16.3 pg/ml vs. 30.1 Ϯ 9.6 pg/ml, respectively; P ϭ 0.48; Fig. 4A ). In contrast, when monocytes and cardiac myofibroblasts were cocultured under direct conditions in which cell-cell contact was permitted, a large increase in TGF-␤ 1 secretion was observed (122.9 Ϯ 10.1 pg/ml; P Ͻ 0.0001; Fig. 4A ). MMP-9, known to activate latent TGF-␤ 1 (12) , was also found to be elevated under direct coculture conditions (3,496.0 Ϯ 190.4 pg/ml in coculture-conditioned media vs. 183.3 Ϯ 43.9 pg/ml when myofibroblasts were cultured in isolation; P Ͻ 0.0001; Fig. 4C ).
Given that TGF-␤ 1 is an established and potent stimulator of myofibroblast activity, we sought to determine whether the increase in TGF-␤ concentration observed is responsible for the monocyte-mediated increase in cardiac myofibroblast activity by adding a function blocking TGF-␤-antibody. Under direct coculture conditions TGF-␤ blockade completely attenuated monocyte-mediated increases in cardiac myofibroblast activity [baseline: 57.6 Ϯ 5.9% vs. atrial cardiac myofibroblasts (aCF)ϩmonocytes (Mo): 65.2 Ϯ 7.1% vs. aCFϩMoϩTGF-␤ blockade: 58.5 Ϯ 2.7% contraction; P Ͻ 0.01; Fig. 4C ]. TGF-␤-blockade did not influence baseline cardiac myofibroblast activity levels (54.4 Ϯ 2.7% contraction; P ϭ 0.10).
Having established that the increase in TGF-␤ is responsible for the monocyte-mediated increase in cardiac myofibroblast activity observed, we sought to determine whether the monocyte-mediated increase in cardiac myofibroblast activity was also dependent upon MMP-9 by adding an MMP-9-specific inhibitor. Under direct coculture conditions, MMP-9 inhibition completely attenuated the monocyte-mediated increase in cardiac fibroblast activity (baseline: 57.6 Ϯ 5.9% vs. aCFϩMo: 65.2 Ϯ 7.1% vs. aCFϩMoϩMMP-9 inhibitor: 55.0 Ϯ 6.0% contraction; P Ͻ 0.05; Fig. 4D ). MMP-9 inhibition did not Fig. 3 . A: schematic representation of baseline (myofibroblasts embedded in the collagen gel), indirect coculture (monocytes seeded onto a transwell insert permeable to paracrine factors, but not cells, placed above the myofibroblastseeded collagen gel) and direct coculture conditions (monocytes and myofibroblasts seeded together into the collagen gel). B: collagen gel contraction, indicative of myofibroblast activity relative to baseline, demonstrating increased collagen gel contraction in the direct coculture group compared with the indirect coculture group (17.9 Ϯ 11.1% vs. 6.4 Ϯ 7.0% increase; n ϭ 4; **P Ͻ 0.01). C: fluorescence immunocytochemistry demonstrating cell-cell interaction (arrowhead) between monocytes (di-8-ANEPPS is denoted by red) and a cardiac myofibroblast (␣-SMA is denoted by green) within the micromatrix model (DAPI is denoted by blue). influence baseline cardiac myofibroblast activity level (58.4 Ϯ 5.9% contraction; P ϭ 0.16).
Monocyte-mediated increase in cardiac myofibroblast activity results in matrix remodeling. We next determined whether the monocyte-mediated increase in cardiac myofibroblast activity results in altered local ECM remodeling using a 3D collagen micromatrix model platform. Coculture of monocytes and cardiac myofibroblasts resulted in a marked increase in cardiac myofibroblast-mediated ECM remodeling compared with baseline, as measured by collagen fiber alignment (1.14 Ϯ 0.16 vs. 0.75 Ϯ 0.14, respectively; P Ͻ 0.001; Figs. 5, A and G). The collagen fiber alignment patterns observed in response to the monocyte-mediated increase in cardiac myofibroblast activity were similar to those observed when cardiac myofibroblasts were stimulated with exogenous TGF-␤ 1 (1.14 Ϯ 0.16 vs. 1.06 Ϯ 0.15, respectively; P ϭ 0.37; Fig. 5, A-G) . Coculture of monocytes and cardiac myofibroblasts within the collagen micromatrix also resulted in increased cardiac myofibroblast activity measured by an increase in the myofibroblast cell extension number and length compared with baseline ( Fig.  5H : 5.2 Ϯ 1.6 vs. 3.0 Ϯ 1.1 extensions, respectively; P Ͻ 0.05; Fig. 5I : 74.1 Ϯ 21.4 m vs. 41.9 Ϯ 8.6 m, respectively; P Ͻ 0.05), confirming that monocytes mediate cardiac myofibroblast activity. These data demonstrate that monocyte-cardiac myofibroblast interaction results in an increased level of cardiac myofibroblast activation and, importantly, this increase in activity translates into increased remodeling of local ECM.
DISCUSSION
Monocytes influence cardiac myofibroblast activity. Inflammation is a potent regulator of the myofibroblast phenotype (9, 16, 41) . Several studies have examined the effect of monocytes on myofibroblasts from tissues other than the heart (33, 42). Wahl et al. (40) demonstrated that monocytes stimulate dermal myofibroblast activity through IL-1␤ and TGF-␤ (40), yet Tsutamoto et al. (38) showed the opposite effect, whereby monocytes inhibited lung-myofibroblast activity. The effect of monocytes on myofibroblasts may be tissue-specific and contextual. In this study, we confirm, for the first time, that human systemic monocytes are a potent stimulator of human cardiacderived myofibroblast activity.
Mechanism of monocyte-mediated increase in cardiac myofibroblast activity. Several proinflammatory cytokines have been implicated as contributing to noncardiac myofibroblast activity, including TNF-␣ (41, 42), IL-1␤ (9), IL-1␣ (42), IL-6 (33, 36), monocyte chemotactic protein-1 (36, 42) , and TGF-␤ (42). Monocytes are a major source of these proinflammatory cytokines following myocardial tissue injury (18) . Our data implicate TGF-␤ 1 and MMP-9 as the primary factors responsible for the monocyte-mediated increase in cardiac myofibroblast activity observed. TGF-␤ has been previously established as a potent stimulator of cardiac myofibroblast activation and ECM dysregulation (5) . Studies have also demonstrated that TGF-␤ is responsible for the cessation of inflammation and the transition to repair following MI (5, 14, 16) . TGF-␤ is known to be secreted by cardiac myofibroblasts and also by monocytes that both migrate to the site of injury post-MI (27, 28, 32) . We demonstrate that inhibition of TGF-␤ activity attenuates the monocyte-mediated increase in cardiac myofibroblast activity, and TGF-␤ release is dependent on direct monocyte-cardiac myofibroblast interactions. We also demonstrate that inhibition of MMP-9 independently attenuates the monocyte-mediated Fig. 4 . A: TGF-␤ concentrations measured in the conditioned media from baseline (21.5 Ϯ 16.3 pg/ml), indirect (30.1 Ϯ 9.6 pg/ml), and direct coculture (122.9 Ϯ 10.1 pg/ml) groups 48 h following treatment by high throughput ELISA (n ϭ 3; ****P Ͻ 0.0001). B: collagen gel contraction demonstrating attenuation of monocyte-mediated myofibroblast activity in the direct coculture group when a function-blocking antibody to TGF-␤ is introduced (65.2 Ϯ 7.1% vs. 58.5 Ϯ 2.7%; n ϭ 5; **P Ͻ 0.01). The addition of the TGF-␤ function-blocking antibody did not significantly influence baseline collagen gel contraction. C: matrix metalloproteinase-9 concentrations in the conditioned media from baseline (183.3 Ϯ 43.9 pg/ml), indirect (981.8 Ϯ 132.7 pg/ml), and direct coculture (3,496.0 Ϯ 190.4 pg/ml) groups 48 h following treatment by high throughput ELISA (n ϭ 3; ****P Ͻ 0.0001). D: collagen gel contraction demonstrating attenuation of monocytemediated myofibroblast activity in the direct coculture group with the addition of an MMP-9 inhibitor (65.2 Ϯ 7.1% vs. 55.0 Ϯ 6.0%; n ϭ 5; **P Ͻ 0.01). The addition of the MMP-9 inhibitor did not significantly influence baseline collagen gel contraction. MMP-9, matrix metalloprotease; ELISA, enzyme-linked immunosorbent assay.
increase in cardiac myofibroblast activity. Given that MMP-9 is also modestly increased under indirect coculture conditions but does not increase cardiac myofibroblast activity in the absence of an increase in TGF-␤, we hypothesize that the pathway by which MMP-9 and TGF-␤ result in increased cardiac myofibroblast activity involves activation of TGF-␤, originally released in its latent form, through cleavage by MMP-9 (15) . Together, these data establish mechanistic evidence to support the influence of cell-mediated inflammation on cardiac fibrosis at the level of the cardiac myofibroblast (Fig. 6) .
Local ECM is remodeled by monocyte activated cardiac myofibroblasts. Several studies equate myofibroblast activation with fibrosis; however, myofibroblast activation is a mere surrogate for the ECM remodeling that defines fibrosis. Therefore, we sought not only to establish the effect of monocytes on cardiac myofibroblast phenotype, but to demonstrate that the monocyte-mediated increase in cardiac myofibroblast activation observed resulting in ECM remodeling of potential clinical significance. Using a 3D collagen micromatrix model, we show that individual monocyte-cardiac myofibroblast interaction results in cardiac myofibroblast activation and subsequent remodeling of the ECM adjacent to these cells.
Clinical implications. Inflammation has been implicated as playing a critical role in the development and progression of both ischemic HF and atrial fibrillation (AF). To date, the only clinical evidence implicating peripheral blood monocytes in cardiac fibrosis relevant to either pathologic process remains Fig. 5 . A-C: confocal immunocytochemistry demonstrating increased cardiac myofibroblast (green denotes ␣-SMA) activation and ECM remodeling (red denotes collagen, while blue denotes DAPI). Collagen fiber alignment measured by peak pixel intensity at given angles within fluorescence immunocytochemistry images of the collagen micromatrix in the baseline (D), TGF-␤-stimulated myofibroblast (E), and monocyte-stimulated myofibroblast (F) groups. G: collagen fiber alignment index indicative of increased extracellular matrix remodeling, above baseline, when monocytes are directly cocultured with cardiac myofibroblasts (0.75 Ϯ 0.14 vs. 1.14 Ϯ 0.16, respectively; n ϭ 9; **P Ͻ 0.01, ***P Ͻ 0.001). H: cardiac myofibroblast activation measured by an increase in cell extension number (3.0 Ϯ 1.1 vs. 5.2 Ϯ 1.6 extensions per cell; n ϭ 9; *P Ͻ 0.05). I: cardiac myofibroblast activation measured by an increase in cell extension length (41.9 Ϯ 8.6 vs. 74.1 Ϯ 21.4 um; n ϭ 25; **P Ͻ 0.01, ***P Ͻ 0.001). ECM, extracellular matrix.
correlational; causative mechanistic links are lacking. Clinical studies demonstrate that patients whom develop monocytosis (particularly, CD14 hi CD16 Ϫ monocytes) following acute MI are more likely to develop ischemic HF (4, 12, 23, 37) . Increasing levels of circulating monocytes have also been shown to predict patients at risk of readmission to hospital for worsening HF, repeat myocardial infarction, and death (41) . Clinical evidence also demonstrates a correlation between monocytosis and the presence of AF; the presence of persistent, as opposed to, paroxysmal AF; and the development of postoperative AF following cardiac surgery (13, 34, 7) . Our data establish a unique and direct mechanistic link between human peripheral blood monocytes and human cardiac myofibroblast-mediated ECM remodeling. Further studies to explore the mechanisms underlying these cellular effects may be useful in the development of novel therapeutic targets to prevent ECM dysregulation and progressive myocardial fibrosis in relation to ischemic HF and AF.
Limitations. We acknowledge that other cellular mechanisms may contribute to monocyte-mediated increases in ECM remodeling beyond cardiac myofibroblast activity alone. For example, monocyte-mediated increases in cardiac myofibroblast proliferation may also contribute to the observed increase in 3D collagen gel remodeling. In addition, cardiac myofibroblasts may affect monocyte phenotype and/or activity, further influencing ECM remodeling. Other cell types found in vivo may also influence monocyte-cardiac myofibroblast interactions and further impact ECM remodeling. These potential mechanisms were not explored in the current study and warrant further investigation.
Peripheral blood monocytes are a heterogeneous population that can be further subdivided by CD14 and CD16 cell surface expression. Clinical data suggest that CD14 hi monocytes were also present in low proportions and their potential influence cannot be discounted. Further investigations are under way to examine the specific effects of each of these distinct monocyte subsets on cardiac myofibroblast activity.
The use of freshly harvested and cultured human cells isolated from both healthy and diseased donors introduces increased potential for variability. We did however, observe a consistent increase in monocyte-mediated cardiac myofibroblast activity regardless of myofibroblast source location or donor phenotype, suggesting that the monocyte-mediated increase in cardiac myofibroblast activity is robust and potentially generalizable to multiple cardiac fibrotic pathologies.
Conclusion. For the first time, we demonstrate that human systemic monocytes increase human cardiac myofibroblasts activity and induce local ECM remodeling through a direct cell-cell mechanism involving the release of TGF-␤ and MMP-9. These observations may have clinical relevance and implications for leveraging novel therapeutic targets to prevent cardiac fibrosis. Monocytes migrate out of circulation into the cardiac interstitium, where they directly interact with cardiac myofibroblasts. This interaction results in release of latent TGF-␤ and MMP-9. MMP-9 activates latent TGF-␤. Activated TGF-␤ then stimulates cardiac myofibroblasts activity, resulting in increased ECM remodeling. MMP-9, matrix metalloproteinase nine.
